Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 4, Number 1—March 1998
Synopsis

Diversity among Multidrug-Resistant Enterococci

Barbara E. MurrayComments to Author 
Author affiliation: University of Texas Houston-Medical School, Houston, Texas, USA

Main Article

Figure 2

Potential modes of spread of vancomycin-resistant genes. Adapted in part from Quintiliani and Courvalin (14).

Figure 2. Potential modes of spread of vancomycin-resistant genes. Adapted in part from Quintiliani and Courvalin (14).

Main Article

References
  1. Murray  BE. The life and times of the enterococcus. Clin Microbiol Rev. 1990;3:46–65.PubMedGoogle Scholar
  2. Moellering  RC Jr. Emergence of enterococcus as a significant pathogen. Clin Infect Dis. 1992;14:1173–8.PubMedGoogle Scholar
  3. Schaberg  DR, Culver  DH, Gaynes  RP. Major trends in the microbial etiology of nosocomial infection. Am J Med. 1991;91(Suppl 3B):72S–5S. DOIPubMedGoogle Scholar
  4. Hodges  TL, Zighelboim-Daum  S, Eliopoulos  GM, Wennersten  C, Moellering  RC Jr. Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens. Antimicrob Agents Chemother. 1992;36:121–5.PubMedGoogle Scholar
  5. Zervos  MJ, Schaberg  DS. Reversal of the in vitro susceptibility of enterococci to trimethoprim-sulfamethoxazole by folinic acid. Antimicrob Agents Chemother. 1985;28:446–8.PubMedGoogle Scholar
  6. Najjar  A, Murray  BE. Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci. Antimicrob Agents Chemother. 1987;31:808–10.PubMedGoogle Scholar
  7. Chenoweth  CE, Robinson  KA, Schaberg  DR. Efficacy of ampicillin versus trimethprim-sulfamethoxazole in a mouse model of lethal enterococcal peritonitis. Antimicrob Agents Chemother. 1990;34:1800–2.PubMedGoogle Scholar
  8. Grayson  ML, Thauvin-Eliopoulos  C, Eliopoulos  GM, Yao  JDC, DeAngelis  DV, Walton  L, Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis. Antimicrob Agents Chemother. 1990;34:1792–4.PubMedGoogle Scholar
  9. Clewell  DB, Keith  EW. Sex pheromones and plasmid transfer in Enterococcus faecalis. Plasmid. 1989;21:175–84. DOIPubMedGoogle Scholar
  10. Clewell  DB. Plasmids, drug resistance, and gene transfer in the genus Streptococcus. Microbiol Rev. 1981;45:409–36.PubMedGoogle Scholar
  11. Clewell  DB. Conjugative transposons and the dissemination of antibiotic resistance in streptococci. Annu Rev Microbiol. 1986;40:635–59. DOIPubMedGoogle Scholar
  12. Roberts  MC. Characterization of the Tet M determinants in urogenital and respiratory bacteria. Antimicrob Agents Chemother. 1990;34:476–8.PubMedGoogle Scholar
  13. Roberts  MC, Hillier  SL. Genetic basis of tetracycline resistance in urogenital bacteria. Antimicrob Agents Chemother 1990;34:261-4.13
  14. Quintiliani  R Jr, Courvalin  P. Characterization of Tn1547, a composite transposon flanked by the IS16 and IS256-like elements, that confers vancomycin resistance in Enterococcus faecalis BM4281. Gene 1996;172:1-8.14
  15. Ferretti  JJ, Gilmore  KS, Courvalin  P. Nucleotide sequence analysis of the gene specifying the bifunctional 6'-aminoglycoside acetyltransferase 2"-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activities. J Bacteriol. 1986;167:631–8.PubMedGoogle Scholar
  16. Carlier  C, Courvalin  P. Emergence of 4',4"-aminoglycoside nucleotidyltransferase in enterococci. Antimicrob Agents Chemother. 1990;34:1565–9.PubMedGoogle Scholar
  17. Chow  JW, Zervos  MJ, Lerner  SA, Thal  LA, Donabedian  SM, Jaworski  DD, A novel gentamicin resistance gene in Enterococcus. Antimicrob Agents Chemother. 1997;41:511–4.PubMedGoogle Scholar
  18. Murray  BE. ß-lactamase-producing enterococci. Antimicrob Agents Chemother. 1992;36:2355–9.PubMedGoogle Scholar
  19. Murray  BE, Singh  KV, Markowitz  SM, Lopardo  HA, Patterson  JE, Zervos  MJ, Evidence for clonal spread of a single strain of ß-lactamase-producing Enterococcus faecalis to six hospitals in five states. J Infect Dis. 1991;163:780–5.PubMedGoogle Scholar
  20. Rhinehart  E, Smith  NE, Wennersten  C, Gorss  E, Freeman  J, Eliopoulos  GM, Rapid dissemination of ß-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N Engl J Med. 1990;323:1814–8.PubMedGoogle Scholar
  21. Wells  VD, Wong  ES, Murray  BE, Coudron  PE, Williams  DS, Markowitz  DM. Infections due to beta-lactamase-producing, high-level gentamicin-resistant Enterococcus faecalis. Ann Intern Med. 1992;116:285–92.PubMedGoogle Scholar
  22. Grayson  ML, Eliopoulos  GM, Wennersten  CB, Ruoff  KL, de Girolami  PC, Ferraro  M-J, Increasing resistance to ß-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob Agents Chemother. 1991;35:2180–4.PubMedGoogle Scholar
  23. Fontana  R, Ligozzi  M, Pittaluga  F, Satta  G. Intrinsic penicillin resistance in enterococci. Microb Drug Resist. 1996;2:209–13. DOIPubMedGoogle Scholar
  24. Rice  LB, Carias  LL, Rudin  SB, Donskey  CJ. Abstract #LB-17 Transferable ampicillin resistance in Enterococcus faecium and linkage of ampicillin and vancomycin-resistance determinants [abstract]. In program of the 37th ICAAC Program Addendum; 1997 Sep 28—Oct1; Toronto, Ontario, Canada.
  25. Perichon  B, Reynolds  P, Van Courvalin  P. D-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother. 1997;41:2016–8.PubMedGoogle Scholar
  26. Derlot  E, Courvalin  P. Mechanisms and implications of glycopeptide resistance in enterococci. Am J Med. 1991;91(Suppl 3B):82S–5S. DOIPubMedGoogle Scholar
  27. Arthur  M, Molinas  C, Bugg  TDH, Wright  GD, Walsh  CT, Courvalin  P. Evidence for in vivo incorporation of D-lactate into peptidoglycan precursors of vancomycin-resistant enterococci. Antimicrob Agents Chemother. 1992;36:867–9.PubMedGoogle Scholar
  28. Dutka-Malen  S, Molinas  C, Arthur  M, Courvalin  P. Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a D-alanine:D-alanine ligase-related protein necessary for vancomycin resistance. Gene. 1992;112:53–8. DOIPubMedGoogle Scholar
  29. Navarro  F, Courvalin  P. Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens. Antimicrob Agents Chemother. 1994;38:1788–93.PubMedGoogle Scholar
  30. Billot-Klein  D, Gutmann  L, Sable  S, Guittet  E, van Heijenoort  J. Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides, and Enterococcus gallinarum. J Bacteriol. 1994;176:2398–405.PubMedGoogle Scholar
  31. Moellering  RC Jr, Wennersten  C, Medrek  T, Weinberg  AN. Prevalence of high-level resistance to aminoglycosides in clinical isolates of enterococci. Antimicrobial agents and chemotherapy--1970. Washington. American Society for Microbiology. 1971;1971:335–40.
  32. Watanakunakorn  C. The prevalence of high-level aminoglycoside resistance among enterococci isolated from blood cultures during 1980-1988. J Antimicrob Chemother. 1989;24:63–8. DOIPubMedGoogle Scholar
  33. Phillips  I, King  A, Gransden  WR, Eykyn  SJ. The antibiotic sensitivity of bacteria isolated from the blood of patients in St. Thomas' Hospital, 1969-1988. J Antimicrob Chemother. 1990;25:59–80.PubMedGoogle Scholar
  34. Zervos  MJ, Dembinski  S, Mikesell  T, Schaberg  DR. High-level resistance to gentamicin in Streptococcus faecalis: risk factors and evidence for exogenous acquisition of infection. J Infect Dis. 1986;153:1075–83.PubMedGoogle Scholar
  35. Eliopoulos  GM, Wennersten  C, Zighelboim-Daum  S, Reiszner  E, Goldmann  D, Moellering  RC Jr. High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium. Antimicrob Agents Chemother. 1988;32:1528–32.PubMedGoogle Scholar
  36. Murray  BE, Singh  KV, Heath  JD, Sharma  BR, Weinstock  GM. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol. 1990;28:2059–63.PubMedGoogle Scholar
  37. Zervos  MJ, Mikesell  TS, Schaberg  DR. Heterogeneity of plasmids determining high-level resistance to gentamicin in clinical isolates of Streptococcus faecalis. Antimicrob Agents Chemother. 1986;30:78–81.PubMedGoogle Scholar
  38. Hodel-Christian  SL, Murray  BE. Characterization of the gentamicin resistance transposon Tn5281 from Enterococcus faecalis and comparison to staphylococcal transposons Tn4001 and Tn4031. Antimicrob Agents Chemother. 1991;35:1147–52.PubMedGoogle Scholar
  39. Hodel-Christian  SL, Smith  M, Zscheck  KZ, Murray  BE. 1991. Comparison of a gentamicin resistance transposon and a beta-lactamase gene from enterococci to those from staphylococci. In: Dunny GM, Cleary PP, McKay LL, editors. Genetics and molecular biology of streptococci, lactococci, and enterococci. Washington: American Society for Microbiology; 1991. p. 54-8.
  40. Thal  LA, Chow  JW, Clewell  DB, Zervos  MJ. Tn924, a chromosome-borne transposon encoding high-level gentamicin resistance in Enterococcus faecalis. Antimicrob Agents Chemother. 1994;38:1152–6.PubMedGoogle Scholar
  41. Rice  LB, Carias  LL, Marshall  SH, Bonafede  ME. Sequences found on staphylococcal ß-lactamase plasmids integrated into the chromosome of Enterococcus faecalis CH116. Plasmid. 1996;35:81–90. DOIPubMedGoogle Scholar
  42. Seetulsingh  PS, Tomayko  JF, Coudron  PE, Markowitz  SM, Skinner  C, Singh  KV, Chromosomal DNA restriction endonuclease digestion patterns of ß-lactamase-producing Enterococcus faecalis isolates collected from a single hospital over a 7-year period. J Clin Microbiol. 1996;34:1892–6.PubMedGoogle Scholar
  43. Tomayko  JF, Murray  BE. Analysis of Enterococcus faecalis isolates from intercontinental sources by multilocus enzyme electrophoresis and pulsed-field gel electrophoresis. J Clin Microbiol. 1995;33:2903–7.PubMedGoogle Scholar
  44. Coudron  PE, Markowitz  SM, Wong  ES. Isolation of a ß-lactamase-producing, aminoglycoside-resistant strain of Enterococcus faecium. Antimicrob Agents Chemother 1992;36:1125-6.44
  45. Patterson  JE, Singh  KV, Murray  BE. Epidemiology of an endemic strain of ß-lactamase-producing Enterococcus faecalis. J Clin Microbiol 1991;29:2513-6.45
  46. Handwerger  S, Perlman  DC, Altarac  D, McAuliffe  V. Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci. Clin Infect Dis 1992;14:655-61.46
  47. Miranda  AG, Singh  KV, Murray  BE. DNA fingerprinting of Enterococcus faecium by pulsed-field gel electrophoresis may be a useful epidemiologic tool. J Clin Microbiol 1991;29:2752-7.47
  48. Handwerger  S, Skoble  J. Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother. 1995;39:2446–53.PubMedGoogle Scholar
  49. Handwerger  S, Skoble  J, Discotto  LF, Pucci  MJ. Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the Northeastern United States. Antimicrob Agents Chemother. 1995;39:362–8.PubMedGoogle Scholar
  50. van den Bogaard  AE, Jensen  LB, Stobberingh  EE. Vancomycin-resistant enterococci in turkeys and farmers. N Engl J Med. 1997;337:1558–9. DOIPubMedGoogle Scholar
  51. Power  EGM, Abdulla  YH, Talsania  HG, Spice  W, Aathithan  S, French  GL. vanA genes in vancomycin-resistant clinical isolates of Oerskovia turbata and Arcanobacterium (Corynebacterium) haemolyticum. J Antimicrob Chemother. 1995;36:595–606. DOIPubMedGoogle Scholar
  52. Poyart  C, Pierre  C, Quesne  G, Pron  B, Berche  P, Trieu-Cuot  P. Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis. Antimicrob Agents Chemother. 1997;41:24–9.PubMedGoogle Scholar
  53. Biavasco  F, Miele  A, Vignaroli  C, Manso  E, Lupid  R, Varaldo  PE. Genotypic characterization of a nosocomial outbreak of VanA Enterococcus faecalis. Microb Drug Resist. 1996;2:231–7. DOIPubMedGoogle Scholar
  54. Boyce  JM, Opal  SM, Chow  JW, Zervos  MJ, Potter-Bynoe  G, Sherman  CB, Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol. 1994;32:1148–53.PubMedGoogle Scholar
  55. Handwerger  S, Raucher  B, Altarac  D, Monka  J, Marchione  S, Singh  KV, Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin and gentamicin. Clin Infect Dis. 1993;16:750–5.PubMedGoogle Scholar
  56. Livornese  LL Jr, Dias  S, Samel  C, Romanowski  B, Taylor  S, May  P, Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med. 1992;117:112–6.PubMedGoogle Scholar
  57. Moreno  F, Grota  P, Crisp  C, Magnon  K, Melcher  GP, Jorgensen  JH, Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis. 1995;21:1234–7.PubMedGoogle Scholar
  58. Perlada  DE, Smulian  AG, Cushion  MT. Molecular epidemiology and antibiotic susceptibility of enterococci in Cincinnati, Ohio: a prospective citywide survey. J Clin Microbiol. 1997;35:2342–7.PubMedGoogle Scholar
  59. Chow  JW, Kuritza  A, Shlaes  DM, Green  M, Sahm  DF, Zervos  MJ. Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hosptials in two states. J Clin Microbiol. 1993;31:1609–11.PubMedGoogle Scholar
  60. Clark  NC, Cooksey  RC, Hill  BC, Swenson  JM, Tenover  FC. Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob Agents Chemother. 1993;37:2311–7.PubMedGoogle Scholar
  61. Sader  HS, Pfaller  MA, Tenover  FC, Hollis  RJ, Jones  RN. Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers. J Clin Microbiol 1994;32:2840-2.61
  62. Boyle  JF, Soumakis  SA, Rendo  A, Herrington  JA, Gianarkis  DG, Thurberg  BE, Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol. 1993;31:1280–5.PubMedGoogle Scholar
  63. Morris  JG Jr, Shay  DK, Hebden  JN, McCarter  RJ Jr, Perdue  BE, Jarvis  W, Enterococci resistant to multiple antimicrobial agents, including vancomycin. Ann Intern Med. 1995;123:250–9.PubMedGoogle Scholar
  64. Bingen  EH, Denamur  E, Lambert-Zechovsky  NY, Elion  J. Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant Enterococcus faecium strains in a pediatric hospital. J Clin Microbiol. 1991;29:1888–92.PubMedGoogle Scholar
  65. Plessis  P, Lamy  T, Donnio  PY, Autuly  F, Grulois  I, LePrise  PY, Epidemiologic analysis of glycopeptide-resistant Enterococcus strains in neutropenic patients receiving prolonged vancomycin administration. Eur J Clin Microbiol Infect Dis. 1995;14:959–63. DOIPubMedGoogle Scholar
  66. Jordens  JZ, Bates  J, Griffiths  DT. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother. 1994;34:515–28. DOIPubMedGoogle Scholar
  67. Klare  I, Heier  H, Claus  H, Bohme  G, Marin  S, Seltmann  G, Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microb Drug Resist. 1995;3:265–72. DOIGoogle Scholar
  68. Van der Auwera  P, Pensart  N, Korten  V, Murray  BE, Leclercq  R. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly-glycopeptide-resistant enterococci. J Infect Dis. 1995;173:1129–36.
  69. Aarestrup  FM, Ahrens  P, Madsen  M, Pallesen  LV, Poulsen  RL, Westh  H. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. Antimicrob Agents Chemother. 1996;40:1938–40.PubMedGoogle Scholar
  70. Bates  J, Jordens  Z, Selkon  JB. Evidence for an animal origin of vancomycin-resistant enterococci [letter]. Lancet. 1993;342:490. DOIPubMedGoogle Scholar
  71. Klare  I, Heier  H, Claus  H, Reissbrodt  R, Witte  W. vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol Lett. 1995;125:165–72. DOIPubMedGoogle Scholar
  72. Schouten  MA, Voss  A, Hoogkamp-Korstanje  JAA. VRE and meat. Lancet. 1997;349:1258. DOIPubMedGoogle Scholar
  73. Coque  TM, Tomayko  JF, Ricke  SC, Okhuysen  PO, Murray  BE. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother. 1996;40:2605–9.PubMedGoogle Scholar
  74. Kjerulf  A, Pallesen  L, Westh  H. Vancomycin-resistant enterococci at a large university hospital in Denmark. APMIS. 1996;104:475–9. DOIPubMedGoogle Scholar
  75. Klare  I, Heier  H, Claus  H, Witte  W. Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides. FEMS Microbiol Lett. 1993;106:23–30. DOIPubMedGoogle Scholar

Main Article

The reference 52 "Poyart, Pierre, Quesne, Pron, Berche, Trieu-Cuot, 1997" is not cited in the text. Please add an in-text citation or delete the reference.

The reference 66 "Jordens, Bates, Griffiths, 1994" is not cited in the text. Please add an in-text citation or delete the reference.

Page created: December 13, 2010
Page updated: December 13, 2010
Page reviewed: December 13, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external